AQUIPTA 60 mg, Tabletten - 28 Swissmedic Key 69128003 Registration Holder AbbVie AG Name AQUIPTA 60 mg, Tabletten Date of registration 06.03.2024 Introduction of Sequence 06.03.2024 ATC-Classification (N02CD07) Revision date WHO WHO-DDD Valid until 05.03.2029 Index Therapeuticus (BSV) 02.05.10. Show package size 28 Index Therapeuticus (Swissmedic) 02.05.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 372.70 Limitation Yes Limitation text
Deductible 10 % Consumer price 421.75 Feedback FB GTIN 7680691280030 Medication Code Synthetika Pharmacode Disponibility
Composition atogepantum 60 mg, copovidonum, tocofersolanum, mannitolum, cellulosum microcristallinum, natrii chloridum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, pro compresso corresp. natrium 31.48 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Atogepantum 60 mg
BAG: Active Agent Dose Atogepantum 60 mg
Inactive agents Carmellosum Natricum Conexum Cellulosum Microcristallinum Copovidonum Mannitol Sodium Chloride Natrii Stearylis Fumaras Pro Compresso Silica Colloidalis Anhydrica Tocofersolanum
Source Data was imported : 04.04.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
